LongeVC Backs HelixNano, a Startup Building a Next-Generation mRNA Therapeutic Platform

Much of our world is made possible by the speed at which technology delivers information and physical products. In the field of biology, mRNA is this same efficient, flexible messenger. With expanded access to mRNA advancements, HelixNano envisions a future where treatments are affordable, progress is decentralized, and biology can be modified instantly with the push of a button.

By concentrating on mRNA advancements from first principles, progress can be made much faster. What used to take months or even years to test can now be accomplished in just a few weeks at a cost that is significantly lower than before.

We are happy to share that Helix Nanotechnologies has joined LongeVC’s portfolio of companies. To learn more about the company, visit their website here.